Sasha Damouni Ellis | executive |
Marianne De Backer | executive |
Phil Pang | executive |
Sung Lee | executive |
Khalil Fenina | analyst |
Yi Zhao | analyst |
Nikola Gasic | analyst |
Eva Xia Privitera | analyst |
Patrick Trucchio | analyst |
Eric Joseph | analyst |
Alec Stranahan | analyst |
Joseph Stringer | analyst |
Michael Ulz | analyst |
Hello. Welcome to Vir Biotechnology's Fourth Quarter and Full-Year 2023 Financial Results and Business Update Call.
As a reminder, this conference call is being recorded. [Operator Instructions] I will now turn the call over to Sasha Damouni Ellis, Executive Vice President, Chief Corporate Affairs Officer.
You may begin, Ms.